Biological E. Limited Vaccine Export Data — India (DGFT 2022–2026)

Name: Biological E. Limited Vaccine Export Records India — #2 Exporter, 859 Shipments, $43.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Vaccine

India Pharmaceutical Trade Intelligence

$1.0B325 Suppliers192 CountriesHS 30024200

ExportsIndia → PAKISTAN8.5%India → NIGERIA8.1%

ImportsFRANCE → India$176.5B GERMANY → India$138.0B

#1 Supplier: SERUM INSTITUTE

Biological E. Limited — Vaccine Exporter #2 | $60.9M Trade Value | TransData Nexus | TransData Nexus

Biological E. Limited — Vaccine Exporter Profile

Indian Pharmaceutical Exporter · #2 for Vaccine · $60.9M export value · DGFT Verified

Biological E. Limited is the #2 Indian exporter of Vaccine with $60.9M in export value and 859 verified shipments. Biological E. Limited holds a 4.1% market share in Vaccine exports across 104 countries. The company exports 5 pharmaceutical products worth $80.3M across 3 therapeutic categories.

Biological E. Limited — Vaccine Export Profile: Buyers & Destinations

Biological E. Limited Vaccine export treemap — buyers and destination countries | TransData Nexus

Where Does Biological E. Limited Export Vaccine?

Country	Value	Shipments	Share
PAKISTAN	$9.7M	210	21.5%
BANGLADESH	$5.5M	114	12.4%
NIGERIA	$2.6M	60	5.8%
ETHIOPIA	$1.9M	39	4.2%

Who Are the Top Buyers of Vaccine from Biological E. Limited?

Buyer	Country	Value	Orders
D.G. CENTRAL MEDICAL STORES DEPT	BANGLADESH	$2.7M	54
MINISTRY OF HEALTH	LAO PEOPLE'S DEMOCRATIC REPUBLIC	$2.2M	50
EXPANDED PROGRAMME ON IMMUNIZATION	PAKISTAN	$2.0M	40
NATIONAL PRIMARY HEALTH CARE	NIGERIA	$1.6M	32
EXPANDED PROGRAM ON IMMUNIZATION	PAKISTAN	$1.5M	30
D.G.CENTRAL MEDICAL STORES DEPT	BANGLADESH	$1.4M	28
AMSON VACCINES AND PHARMA PRIVATE LIMITED	PAKISTAN	$1.0M	25
MINISTERE DE LA SANTE	MOROCCO	$850.0K	17
AMSON VACCINES AND PHARMA PVT LTD.,	PAKISTAN	$748.9K	16
PERMANENT SECRETARY	TANZANIA	$700.0K	14

Biological E. Limited supplies Vaccine to 350 buyers globally. The largest buyer is D.G. CENTRAL MEDICAL STORES DEPT (BANGLADESH), followed by MINISTRY OF HEALTH (LAO PEOPLE'S DEMOCRATIC REPUBLIC) and EXPANDED PROGRAMME ON IMMUNIZATION (PAKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Vaccine Formulations Does Biological E. Limited Export?

Product Description / Formulation	Value	Shipments
DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLY	$4.6M	100
DTP-HEPB-HIB (PENTAVALENT VACCINE) DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLY LIQUID COMBINATION VACCINE,SINGLE DOSE	$2.6M	58
MR VACCINE MEASLES AND RUBELLA VACCINE C	$1.5M	31
TYPHOID CONJUGATE VACCINE MONOVALENT 5 DOSE 2.5ML VIAL WITH VACCINE VIAL MONITOR(VVM)	$1.5M	32
DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLYLIQUID COMBINATION VACCINE 10 DOSE VIALPAEDIARIC DOSE DIPHTHERIA,TETANUS,**	$1.3M	28
S359348 MR VACCINE MEASLES AND RUBELLA	$1.3M	27
DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLYLIQUID COMBINATION VACCINE, 10 DOSE (5ML) VIAL	$1.1M	22
MR VACCINE MEASLES AND RUBELLA VACCINE COMBINED VIAL OF 5 DOSES WITH DILUENT. WITH VACCINE VIAL MONITOR (VVM)	$1.1M	22
DTP-HEPB-HIB (PENTAVALENT VACCINE) DTP-H	$1.0M	21
DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLYLIQUID COMBINATION VACCINE,SINGLE DOSEVIAL(0.5ML) VIAL,PEDIATRIC DOSE **	$900.0K	18

Biological E. Limited exports 411 distinct Vaccine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLY with 100 shipments worth $4.6M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Biological E. Limited Compare to Nearest Vaccine Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	SERUM INSTITUTE OF INDIA PRIVATE LIMITED	$161.3M	3,225	164	$50.0K
2	BIOLOGICAL E. LIMITED ★	$43.0M	859	104	$50.0K
3	BHARAT BIOTECH INTERNATIONAL LIMITED	$30.4M	609	77	$50.0K
6	INDIAN IMMUNOLOGICALS LIMITED	$20.1M	403	34	$50.0K

Biological E. Limited ranks #2 among 325 Indian Vaccine exporters. Average shipment value of $50.0K compared to the market average of $964.0K. The closest competitors by value are SERUM INSTITUTE OF INDIA PRIVATE LIMITED and BHARAT BIOTECH INTERNATIONAL LIMITED.

Which Indian Ports Ship Vaccine Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	3,489	24.3%
SAHAR AIR	2,995	20.9%
Bombay Air	855	6.0%
HYDERABAD ACC (INHYD4)	839	5.8%
HYDERABAD AIR	805	5.6%
DELHI AIR CARGO ACC (INDEL4)	752	5.2%
DELHI AIR	581	4.0%
AHEMDABAD AIR ACC (INAMD4)	373	2.6%

Geopolitical & Trade Policy Impact on Biological E. Limited's Vaccine Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like BE. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight charges and potential losses estimated between ₹2,500 crore and ₹5,000 crore for the Indian pharma industry in March 2026. (fortuneindia.com) These disruptions can elongate lead times and elevate cold-chain failure risks, particularly for temperature-sensitive products like vaccines. (pharmaceuticalcommerce.com)

Conversely, U.S.-China trade tensions have prompted the U.S. to seek alternative suppliers, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the U.S. in August 2025 posed challenges, with Indian exporters facing increased costs and competitive disadvantages. (apnews.com) The subsequent withdrawal of tariffs on generic drugs in October 2025 provided some relief, yet the episode underscores the volatility of trade policies and the need for exporters to remain agile. (medboundtimes.com)

In the European Union, compliance with the Falsified Medicines Directive requires stringent serialization and traceability measures. For companies like BE, ensuring adherence to these regulations is crucial to maintain market access and uphold their reputation for quality.

Biological E. Limited — Regulatory Compliance & Quality Standards

Regulatory compliance remains a cornerstone for Indian pharmaceutical exporters. The U.S. FDA has intensified inspections, with over 200 conducted in 2023 and plans to increase this number in 2024. (fact.net.in) Instances of quality issues and FDA warnings have previously affected the reputation of Indian pharma exports. (svhealthcare.in) For BE, maintaining compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP) is imperative to sustain and expand its export footprint.

The company's recent WHO pre-qualification for nOPV2 reflects its commitment to quality and regulatory excellence. However, the broader industry faces challenges related to counterfeit drugs and quality concerns, which can impact India's reputation as a reliable supplier. (fact.net.in) Proactive measures, including robust quality assurance systems and transparent governance, are essential for BE to navigate this evolving landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Biological E. Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 1,218 individual customs records matching Biological E. Limited exporting Vaccine, covering 411 formulations to 128 countries via 350 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 192+ countries, 2,202+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Vaccine

Vaccine

Biological E. Limited — Vaccine Exporter Profile

Biological E. Limited — Vaccine Export Profile: Buyers & Destinations

Where Does Biological E. Limited Export Vaccine?

Who Are the Top Buyers of Vaccine from Biological E. Limited?

What Is India's Total Vaccine Export Value and How Much Does Biological E. Limited Contribute?

What Is the Average Shipment Value for Biological E. Limited's Vaccine Exports?

How Does Biological E. Limited Compare to Other Indian Vaccine Exporters?

What Vaccine Formulations Does Biological E. Limited Export?

Regulatory Requirements: Exporting Vaccine to Key Markets

Nigeria — NAFDAC

How Does Biological E. Limited Compare to Nearest Vaccine Exporters?

Which Indian Ports Ship Vaccine Exports?

What Other Other Products Does Biological E. Limited Export?

Vaccine — Export Intelligence Video

Geopolitical & Trade Policy Impact on Biological E. Limited's Vaccine Exports

Biological E. Limited — Regulatory Compliance & Quality Standards

About Biological E. Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Vaccine Export Data from Biological E. Limited

Vaccine Stats

Company Overview

Top Products by Biological E. Limited

Related Analysis

Need Detailed Export Data?

Data Source